In a clinical study with biomarker data managed by an external partner, what should be the data flow? Is there an obligation to store these data into the clinical database? Or can they be transfered directly to statistician team? What about the coding or anonymization of these type of data at CRO and at Sponsor?
RECOMMENDED
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More